Valeant names interim chief while Pearson is ill

8 January 2016 - Deborah Wilkes


Valeant Pharmaceuticals International has appointed Howard Schiller as interim chief executive officer, while Michael Pearson remains on "medical leave of absence".

Click tags below for more information on topics:

Bausch Health

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: